Susan Lynch

Susan Lynch, M.D., directs the Microbiome Research Core and acts as associate director of the Microbiome in Inflammatory Disease Program. Her research program focuses primarily on the gastrointestinal microbiome, and its role in both the origins of, and established chronic inflammatory diseases. Dr. Lynch has been awarded the Rebecca Buckley Lectureship by the American Academy of Allergy, Asthma and Immunology, featured in International Innovation: Women in Healthcare, and named one of Foreign Policy magazine’s “Global Thinkers” in 2016. She is an American Society of Microbiology Distinguished Lecturer, serves on the National Academy of Science Committee on Advancing Understanding of the Implications of Environmental-Chemical Interactions with the Human Microbiomes and has recently founded Siolta Therapeutics, which develops next-generation microbiome therapeutics.